PCRX
Price
$25.22
Change
+$0.03 (+0.12%)
Updated
Aug 12, 12:06 PM (EDT)
Capitalization
1.13B
79 days until earnings call
SNDL
Price
$2.05
Change
+$0.04 (+1.99%)
Updated
Aug 12, 12:34 PM (EDT)
Capitalization
517.27M
97 days until earnings call
Interact to see
Advertisement

PCRX vs SNDL

Header iconPCRX vs SNDL Comparison
Open Charts PCRX vs SNDLBanner chart's image
Pacira BioSciences
Price$25.22
Change+$0.03 (+0.12%)
Volume$700
Capitalization1.13B
SNDL
Price$2.05
Change+$0.04 (+1.99%)
Volume$21.8K
Capitalization517.27M
PCRX vs SNDL Comparison Chart in %
Loading...
PCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PCRX vs. SNDL commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCRX is a StrongBuy and SNDL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (PCRX: $25.18 vs. SNDL: $2.01)
Brand notoriety: PCRX and SNDL are both not notable
PCRX represents the Pharmaceuticals: Generic, while SNDL is part of the Beverages: Alcoholic industry
Current volume relative to the 65-day Moving Average: PCRX: 79% vs. SNDL: 519%
Market capitalization -- PCRX: $1.13B vs. SNDL: $517.27M
PCRX [@Pharmaceuticals: Generic] is valued at $1.13B. SNDL’s [@Beverages: Alcoholic] market capitalization is $517.27M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $66.04B to $0. The market cap for tickers in the [@Beverages: Alcoholic] industry ranges from $19.33T to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.64B. The average market capitalization across the [@Beverages: Alcoholic] industry is $6.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCRX’s FA Score shows that 0 FA rating(s) are green whileSNDL’s FA Score has 0 green FA rating(s).

  • PCRX’s FA Score: 0 green, 5 red.
  • SNDL’s FA Score: 0 green, 5 red.
According to our system of comparison, both PCRX and SNDL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCRX’s TA Score shows that 4 TA indicator(s) are bullish while SNDL’s TA Score has 6 bullish TA indicator(s).

  • PCRX’s TA Score: 4 bullish, 5 bearish.
  • SNDL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SNDL is a better buy in the short-term than PCRX.

Price Growth

PCRX (@Pharmaceuticals: Generic) experienced а +9.76% price change this week, while SNDL (@Beverages: Alcoholic) price change was +22.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +5.61%. For the same industry, the average monthly price growth was +11.38%, and the average quarterly price growth was +81.44%.

The average weekly price growth across all stocks in the @Beverages: Alcoholic industry was -0.09%. For the same industry, the average monthly price growth was -4.78%, and the average quarterly price growth was -9.33%.

Reported Earning Dates

PCRX is expected to report earnings on Oct 30, 2025.

SNDL is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+5.61% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Beverages: Alcoholic (-0.09% weekly)

The alcoholic beverage market includes beer, wine, and spirits. From $230 billion in 2015, the industry has grown to around $250 billion by 2019. In recent years, alcoholic beverage makers have been looking to expand distribution and purchase channels, such as through online stores (e.g. e-commerce platform Drizly) and convenience stores. Anheuser-Busch In Bev and Diageo are major global alcoholic beverage companies, while U.S.-owned companies include Constellation Brands and Brown-Forman Corp. among several others.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCRX($1.13B) has a higher market cap than SNDL($517M). PCRX YTD gains are higher at: 33.652 vs. SNDL (12.291). PCRX has higher annual earnings (EBITDA): 28M vs. SNDL (-39.96M). PCRX has more cash in the bank: 494M vs. SNDL (212M). SNDL has less debt than PCRX: SNDL (151M) vs PCRX (636M). SNDL has higher revenues than PCRX: SNDL (944M) vs PCRX (703M).
PCRXSNDLPCRX / SNDL
Capitalization1.13B517M219%
EBITDA28M-39.96M-70%
Gain YTD33.65212.291274%
P/E Ratio12.90N/A-
Revenue703M944M74%
Total Cash494M212M233%
Total Debt636M151M421%
FUNDAMENTALS RATINGS
PCRX vs SNDL: Fundamental Ratings
PCRX
SNDL
OUTLOOK RATING
1..100
783
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
66
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9494
PRICE GROWTH RATING
1..100
4138
P/E GROWTH RATING
1..100
10092
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PCRX's Valuation (57) in the Pharmaceuticals Other industry is in the same range as SNDL (66) in the null industry. This means that PCRX’s stock grew similarly to SNDL’s over the last 12 months.

PCRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as SNDL (100) in the null industry. This means that PCRX’s stock grew similarly to SNDL’s over the last 12 months.

PCRX's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as SNDL (94) in the null industry. This means that PCRX’s stock grew similarly to SNDL’s over the last 12 months.

SNDL's Price Growth Rating (38) in the null industry is in the same range as PCRX (41) in the Pharmaceuticals Other industry. This means that SNDL’s stock grew similarly to PCRX’s over the last 12 months.

SNDL's P/E Growth Rating (92) in the null industry is in the same range as PCRX (100) in the Pharmaceuticals Other industry. This means that SNDL’s stock grew similarly to PCRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PCRXSNDL
RSI
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
68%
Bullish Trend 1 day ago
73%
Declines
ODDS (%)
Bearish Trend 7 days ago
78%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
PCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDVTX12.57N/A
N/A
Hartford International Equity R5
NBPTX48.85N/A
N/A
Neuberger Berman Large Cap Value Tr
JIGZX88.10N/A
N/A
JPMorgan U.S. GARP Equity R2
MSJIX19.53N/A
N/A
Morgan Stanley Global Endurance I
JYEBX11.85N/A
N/A
JHancock Real Estate Securities A

PCRX and

Correlation & Price change

A.I.dvisor tells us that PCRX and ELAN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCRX and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCRX
1D Price
Change %
PCRX100%
N/A
ELAN - PCRX
32%
Poorly correlated
+2.58%
TEVA - PCRX
28%
Poorly correlated
+0.31%
ACET - PCRX
27%
Poorly correlated
-3.96%
SNDL - PCRX
26%
Poorly correlated
+19.64%
NBIX - PCRX
25%
Poorly correlated
-0.84%
More

SNDL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDL has been closely correlated with CGC. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNDL jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDL
1D Price
Change %
SNDL100%
+19.64%
CGC - SNDL
77%
Closely correlated
+26.11%
TLRY - SNDL
76%
Closely correlated
+41.82%
CRON - SNDL
73%
Closely correlated
+16.09%
OGI - SNDL
68%
Closely correlated
+13.15%
ACB - SNDL
65%
Loosely correlated
+16.52%
More